Dan Omstead
Chief Executive Officer chez ABRDN HEALTHCARE OPPORTUNITIES FUND
Fortune : 6 M $ au Aujourd'hui
Profil
Daniel R.
Omstead's current job(s) include being the President, Chief Executive Officer & Trustee at abrdn Healthcare Opportunities Fund, the Director-Emeritus at Heading Home, Inc., the Director at HotSpot Therapeutics, Inc., the President & Trustee at abrdn Healthcare Investors, the President & Trustee at abrdn Life Sciences Investors, the President & Trustee at abrdn World Healthcare Fund, the Principal at abrdn, Inc., and the President & Trustee at Tekla Income Edge Fund.
Dr. Omstead's former job(s) include being the President & Chief Executive Officer at Tekla Capital Management LLC, the President & Chief Executive Officer at Reprogenesis, Inc., the Chairman at Veniti, Inc., a Director at Agilix Corp., a Director at Idun Pharmaceuticals, Inc., an Independent Director at Celladon Corp., a Director at Tibion Corp., a Director at IlluminOss Medical, Inc., a Director at Ebi Life Sciences, Inc., a Director at Neurovance, Inc., a Director at Concentric Medical, Inc., a Director at Magellan Diagnostics, Inc., a Director at Elemé Medical, Inc., a Director at CardioKinetix, Inc., a Senior Director at R.W.
Johnson Pharmaceutical Research Institute, a Director at DynexCorp Ltd., a Director at Palyon Medical Corp., a Director at Insightra Medical, Inc., a Director at Euthymics Bioscience, Inc., a Director at Veracyte SD, Inc., a Senior Vice President-Research & Development at CytoTherapuetics, Inc., a Trustee at Joslin Diabetes Center, Inc., and a Principal at Ortho Pharmaceutical Corp.Dr. Omstead's education history includes a graduate and doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Lehigh University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/09/2023 | 178 269 ( 0,37% ) | 3 M $ | 31/03/2024 | |
| 25/09/2023 | 197 518 ( 0,75% ) | 3 M $ | 31/03/2024 | |
| 17/03/2020 | 24 326 ( inf% ) | - $ | Aujourd'hui |
Postes actifs de Dan Omstead
| Sociétés | Poste | Début |
|---|---|---|
| ABRDN HEALTHCARE INVESTORS | President | 01/01/2001 |
| ABRDN LIFE SCIENCES INVESTORS | President | 01/01/2001 |
| ABRDN WORLD HEALTHCARE FUND | President | 05/03/2015 |
| ABRDN HEALTHCARE OPPORTUNITIES FUND | Chief Executive Officer | 01/01/2014 |
Heading Home, Inc.
 Heading Home, Inc. Services to the Health IndustryHealth Services Heading Home, Inc. provides emergency, transitional and permanent housing, and support services. The firm offers services to ow-income homeless and formerly homeless families and individuals in the communities of Boston, Cambridge, Somerville, Medford, Malden, Everett, Quincy, Chelsea and Revere. The company was founded in 1974 and is headquartered in Charlestown, MA. | Director/Board Member | - |
Tekla Income Edge Fund
 Tekla Income Edge Fund Investment Trusts/Mutual FundsMiscellaneous Tekla Income Edge Fund is a non-diversified, closed-end investment company that will engage in investment activities. It expects to invest in U.S. and non-U.S. equity and debt securities of companies in the healthcare industry, including, but not limited to, biotechnology, pharmaceutical, medical devices and healthcare services companies. The fund is headquartered in Boston, MA. | President | - |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Director/Board Member | 01/01/2021 |
abrdn, Inc.
 abrdn, Inc. Investment ManagersFinance abrdn, Inc. is SEC-registered investment advisor and mutual fund manager headquartered in Philadelphia, Pennsylvania. Founded in 1995, the firm was formerly known as Aberdeen Asset Management, Inc. and as Aberdeen Standard Investments, Inc. until it became abrdn, Inc. in 2022. They are a subsidiary of abrdn Holdings Ltd., ultimately held by abrdn Plc (LON: ABDN) in Great Britain. abrdn provides investment products and solutions to various clients across the world. | Portfolio Manager-Equities | - |
Anciens postes connus de Dan Omstead
| Sociétés | Poste | Fin |
|---|---|---|
IlluminOss Medical, Inc.
 IlluminOss Medical, Inc. Medical SpecialtiesHealth Technology IlluminOss Medical, Inc. engages in the designing, developing, and marketing of orthopedic fracture repair products. The company was founded by Robert A. Rabiner and Arnold-Peter C. Weiss in 2007 and is headquartered in East Providence, RI. | Director/Board Member | 01/01/2020 |
| ░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Dan Omstead
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Lehigh University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 31 |
|---|---|
abrdn Healthcare Investors
 abrdn Healthcare Investors Investment Trusts/Mutual FundsMiscellaneous Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA. | Miscellaneous |
abrdn Life Sciences Investors
 abrdn Life Sciences Investors Investment Trusts/Mutual FundsMiscellaneous abrdn Healthcare Investors operates as a closed-end investment fund, which engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA. | Miscellaneous |
Agilix Corp.
 Agilix Corp. Medical SpecialtiesHealth Technology Agilix Corp. develops genomics and proteomics platform technologies for the systematic discovery and analysis of genes, protein products and related biological functions. The company was founded in 1999 and is headquartered in New Haven, CT. | Health Technology |
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Health Technology |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Health Technology |
Tibion Corp.
 Tibion Corp. Medical SpecialtiesHealth Technology Tibion Corp. designs and develops medical devices. It develops innovative equipment that helps individuals recover physical function lost due to disease, trauma or aging. The company was founded was founded by Kern Bhugra and Robert Horst in 2002 and is headquartered in Sunnyvale, CA. | Health Technology |
IlluminOss Medical, Inc.
IlluminOss Medical, Inc. Medical SpecialtiesHealth Technology IlluminOss Medical, Inc. engages in the designing, developing, and marketing of orthopedic fracture repair products. The company was founded by Robert A. Rabiner and Arnold-Peter C. Weiss in 2007 and is headquartered in East Providence, RI. | Health Technology |
Ebi Life Sciences, Inc.
 Ebi Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ebi Life Sciences, Inc. is a private company that specializes in researching and developing life sciences. The company is based in Cambridge, MA. | Commercial Services |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
abrdn World Healthcare Fund
 abrdn World Healthcare Fund Investment Trusts/Mutual FundsMiscellaneous Tekla World Healthcare Fund is a closed-end management investment company, which engages in investing in the healthcare industry. Its objective is to seek current income and long-term capital appreciation through investment companies engaged in the healthcare industry, including equity securities and debt securities. The company was founded on March 5, 2015 and is headquartered in Boston, MA. | Miscellaneous |
abrdn, Inc.
abrdn, Inc. Investment ManagersFinance abrdn, Inc. is SEC-registered investment advisor and mutual fund manager headquartered in Philadelphia, Pennsylvania. Founded in 1995, the firm was formerly known as Aberdeen Asset Management, Inc. and as Aberdeen Standard Investments, Inc. until it became abrdn, Inc. in 2022. They are a subsidiary of abrdn Holdings Ltd., ultimately held by abrdn Plc (LON: ABDN) in Great Britain. abrdn provides investment products and solutions to various clients across the world. | Finance |
Tekla Capital Management LLC
 Tekla Capital Management LLC Investment ManagersFinance Tekla Capital Management LLC is an independent, SEC-registered investment advisor headquartered in Boston, Massachusetts. Formerly known as Hambrecht & Quist Capital Management LLC, the firm serves as an investment adviser for four closed-end funds – Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. | Finance |
Reprogenesis, Inc.
 Reprogenesis, Inc. BiotechnologyHealth Technology Reprogenesis, Inc., located in Cambridge, Massachusetts developes tissue engineered therapies to treat unmet medical needs. The Company has proprietary technology utilizing the combination of cells and biomaterials to restore, repair or replace lost tissue or physiological function. The Company has a broad preclinical and clinical pipeline of products in the areas of urology, cardiovascular biology and plastic and reconstructive surgery. ChondrogelTM is its most advanced product | Health Technology |
Concentric Medical, Inc.
 Concentric Medical, Inc. Medical SpecialtiesHealth Technology Concentric Medical, Inc. designs, manufactures and distributes medical devices. The company was founded in August 1999 and is headquartered in Kalamazoo, MI. | Health Technology |
| CytoTherapuetics, Inc. | Finance |
Magellan Diagnostics, Inc.
 Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Magellan Diagnostics, Inc. develops diagnostic laboratory products. It products include LeadCare II System and LeadCare Ultra. The firm's services encompass blood lead and zinc protoporphyrin analysis. The company was founded in 1968 and is headquartered in North Billerica, MA. | Health Technology |
Joslin Diabetes Center, Inc.
 Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA. | Health Technology |
Elemé Medical, Inc.
 Elemé Medical, Inc. Medical SpecialtiesHealth Technology Elemé Medical, Inc. manufactured laser-based cellulite treatment. The firm’s products included SmoothShapes with Photomology technology, a medical device for the temporary reduction in the appearance of cellulite and SmoothLipo, a medical device for laser-assisted lipolysis that is used in body shaping and skin tightening of localized areas. The company was founded by R. Robert Nagel and was headquartered in Merrimack, NH. | Health Technology |
CardioKinetix, Inc.
 CardioKinetix, Inc. Medical SpecialtiesHealth Technology CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA. | Health Technology |
| R.W. Johnson Pharmaceutical Research Institute | |
| Ortho Pharmaceutical Corp. | |
DynexCorp Ltd.
 DynexCorp Ltd. Investment ManagersFinance DynexCorp Ltd. provides investment advisory services. The private company is based in Geneva, Switzerland. | Finance |
Palyon Medical Corp.
 Palyon Medical Corp. Medical SpecialtiesHealth Technology Palyon Medical Corp. develops medical devices for the treatment of chronic pain, spasticity and other neurological diseases. The company was founded by Greg David, David A. Present and Klaus G. Lederer on May 16, 2003 and is headquartered in Santa Clarita, CA. | Health Technology |
Insightra Medical, Inc.
 Insightra Medical, Inc. Medical SpecialtiesHealth Technology Insightra Medical, Inc. develops medical devices. It offers QuickWIT, a cardiology wire insertion tool, sensiPull, an ergonomic aortic punch, and the Modulare, a catheter stabilization device. The firm also offers innovative solutions for the common disease of inguinal hernias and ventral hernia. The company was founded by Bradley J. Sharp in March 2001 and is headquartered in Irvine, CA. | Health Technology |
Heading Home, Inc.
Heading Home, Inc. Services to the Health IndustryHealth Services Heading Home, Inc. provides emergency, transitional and permanent housing, and support services. The firm offers services to ow-income homeless and formerly homeless families and individuals in the communities of Boston, Cambridge, Somerville, Medford, Malden, Everett, Quincy, Chelsea and Revere. The company was founded in 1974 and is headquartered in Charlestown, MA. | Health Services |
Euthymics Bioscience, Inc.
 Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Veracyte SD, Inc.
 Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA. | Commercial Services |
abrdn Healthcare Opportunities Fund
 abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Tekla Healthcare Opportunities Fund operates as a closed-end investment fund and investment trust. The trust's investment objective is to seek current income and long-term capital appreciation through investing in companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. The Trust was founded on April 2, 2014 and is headquartered in Boston, MA. | Miscellaneous |
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Health Technology |
Tekla Income Edge Fund
Tekla Income Edge Fund Investment Trusts/Mutual FundsMiscellaneous Tekla Income Edge Fund is a non-diversified, closed-end investment company that will engage in investment activities. It expects to invest in U.S. and non-U.S. equity and debt securities of companies in the healthcare industry, including, but not limited to, biotechnology, pharmaceutical, medical devices and healthcare services companies. The fund is headquartered in Boston, MA. | Miscellaneous |
Veniti, Inc.
 Veniti, Inc. Medical SpecialtiesHealth Technology Veniti, Inc. operates as a medical device company which focuses on the treatment of venous insufficiency. Its products include VENI RF Plus which uses radio frequency generated steam to destroy problematic veins that manifest as varicose veins; VENI Vena Cava Filter system which is engineered to improve the accuracy, efficiency of deployment, placement and retrieval; and VICI Venous Stent which is designed specifically for the treatment of venous outflow obstruction. The company was founded by Sean C. Morris and Mark Klopp in 2009 and is headquartered in Fremont, CA. | Health Technology |
